Public Health: This looks to me to be a huge deal, and to be prefiguring other huge deals. First mRNA vaccines, then semaglutides, and now this—the biotech piece of the next mode-of-production is barreling down the track toward us with greatly increasing speed:

Adam Feurstein: In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease <statnews.com/2023/12/08…>: ‘Casgevy… by Vertex Pharmaceuticals and CRISPR scientific triumph for the technology that can efficiently and precisely repair DNA mutations—ushering in a new era of genetic medicines for inherited diseases…. Casgevy was shown to eliminate recurrent episodes of debilitating pain…. Casgevy… edits a patient’s own blood stem cells to produce high levels of fetal hemoglobin—the healthy, oxygen-carrying form of the protein…